Video

Regulation of Compounding Pharmacies

David G. Miller, RPh, discusses whether and how regulation of compounding pharmacies needs to change.

In this video, shot at the National Community Pharmacists Association 115th Annual Convention in Orlando, David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists, discusses whether and how regulation of compounding pharmacies needs to change in the wake of the meningitis outbreak caused by tainted steroids produced by the New England Compounding Center.

Related Videos
California Wildfires, Pharmacies, Community | image Credit: J Bettencourt/peopleimages.com | stock.adobe.com
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Woman professional nutritionist checking dietary supplements in hand, surrounded by a variety of fruits, nuts, vegetables, and dietary supplements on the table - Image credit: amenic181 | stock.adobe.com
Related Content
Tuberous sclerosis complex written on easel | Image Credit: © Yurii Kibalnik - stock.adobe.com
January 29th 2025

Generic Everolimus Receives FDA Approval for Treatment of Tuberous Sclerosis Complex

Alexandra Gerlach, Associate Editor
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
As of January 24, 2025, there have been 67 confirmed active cases in Wyandotte and Johnson counties in Kansas. | Image Credit: Dr_Microbe | stock.adobe.com
January 29th 2025

Kansas Reports Historic Numbers of Active Tuberculosis Cases

Ashley Gallagher, Editor
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
Man with hepatitis MASH -- Image credit: Orawan | stock.adobe.com
January 29th 2025

Mitochondrial Dysfunction Present in Visceral Adipose Tissue in Patients With Obesity-Related MASH

Gillian McGovern, Associate Editor
Ozempic and Wegovy semaglutide pens with pink tape measure
Published: January 28th 2025 | Updated: January 28th 2025

FDA Approves Semaglutide to Reduce Kidney Disease, Cardiovascular Death Risk in Adults With Type 2 Diabetes, Chronic Kidney Disease

Luke Halpern, Assistant Editor